Skip to content

Clinical trials

Lung Diseases, Interstitial trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Country / region: Canada Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20081
20102
20112
20132
20141
20162
20176
20181
20195
20204
20214
20225
20236
202410
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting16
Terminated10
Unknown status6
Active, not recruiting6
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim8
Laval University4
Centre hospitalier de l'Université de Montréal (CHUM)3
United Therapeutics3
University of Alberta3
Bristol-Myers Squibb2
Celgene2
Hoffmann-La Roche2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2
McGill University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial61
Idiopathic Pulmonary Fibrosis12
Pulmonary Disease, Chronic Obstructive12
Pulmonary Fibrosis11
Dyspnea6
Hypertension, Pulmonary6
Scleroderma, Diffuse5
Scleroderma, Systemic5
Fibrosis4
Lung Diseases4

Trials

Showing 76 to 61 of 61. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.